Showing 3141-3150 of 5621 results for "".
- Practitioners Should Be Aware of Mask-Associated Dry Eye (MADE)https://modernod.com/news/core-alerts-practitioners-to-mask-associated-dry-eye-made/2478221/Widespread use of face masks has been determined essential to combat COVID-19’s spread, yet is giving rise to a new phenomenon: increased reports of dry eyes. Experts from the Centre for Ocular Research & Education (CORE) are advising eye care professionals on how to recognize mask-associated
- Vision Expo to Host Virtual Career Zone Event on September 22https://modernod.com/news/vision-expo-to-host-virtual-career-zone-event-on-september-22/2478215/Vision Expo announced plans to host the Virtual Career Zone, a virtual networking event designed to connect young professionals and students with prominent optical companies. Set to take place on Tuesday, September 22 from 11-11:55 a.m. EDT, the virtual event is inspired by Vision Expo’s o
- Amazon Enters Health-Tracking Space With Halo Wristband, App Debuthttps://modernod.com/news/amazon-enters-health-tracking-space-with-halo-wristband-app-debut/2478213/Amazon introduced Halo on Thursday, a subscription service that uses an app and wristband to monitor an individual’s overall health and wellness, including activity, sleep and body fat, as well as tone of voice to analyze emotional well-being. “We are using Amazo
- Moderna’s COVID-19 Vaccine Candidate Shows Promise in Older Adultshttps://modernod.com/news/modernas-covid-19-vaccine-candidate-shows-promise-in-older-adults/2478211/Interim data from a phase 1 study presented by Moderna showed that its experimental vaccine mRNA-1273 was safe and generated an immune response in people over the age of 55. Results from cohorts of older adults aged 56 to 70 years, as well as elderly participants 71 years and older, were detailed
- AGTC Announces Publication of Preclinical Data that Support the Ongoing Clinical Development of Its XLRP Gene Therapy Programhttps://modernod.com/news/agtc-announces-publication-of-preclinical-data-that-support-the-ongoing-clinical-development-of-its-xlrp-gene-therapy-program/2478200/Applied Genetic Technologies Corporation (AGTC) announced that preclinical data validating the transgene (hRPGRco) that is being evaluated in the company’s ongoing phase 1/2 clinical trial in patients with X-lined retinitis pigmentosa (XLRP) have been published in the July 15, 2020 print issue of
- EU Wraps Up Advanced Talks With Moderna for COVID-19 Vaccine Supply Dealhttps://modernod.com/news/eu-wraps-up-advanced-talks-with-moderna-for-covid-19-vaccine-supply-deal/2478195/The European Commission said Monday that it concluded exploratory talks with Moderna for an initial purchase of 80 million doses of the company’s mRNA vaccine candidate against SARS-CoV-2. The contractual framework would also provide an option for EU member states to purchase an additional
- Supreme Court to Hear Arguments on Pivotal Case That Decides Fate of ACA After Electionhttps://modernod.com/news/supreme-court-to-hear-arguments-on-pivotal-case-that-decides-fate-of-aca-after-election/2478180/The Supreme Court will hear oral arguments in a lawsuit over the constitutionality of the Affordable Care Act (ACA) on November 10, a week after the presidential election, according to a FierceHealthcare
- Nearly Half of Physicians Believe It Will Take a Year to Get COVID-19 Under Controlhttps://modernod.com/news/nearly-half-of-physicians-believe-it-will-take-a-year-to-get-covid-19-under-control/2478174/The majority of physicians believe COVID-19 won’t be under control until January 2021, and nearly half (49%) expect it will take much longer to get the virus under control, according to a FierceHealthcare
- Alcon Canada introduces PRECISION1 Contact Lenseshttps://modernod.com/news/alcon-canada-introduces-precision1-contact-lenses/2478144/Alcon has launched the PRECISION1 daily disposable, silicone hydrogel (SiHy) contact lenses in Canada. Designed to address the common issues that cause 1-in-5 new wearers to discontinue contact lens within the first year (poor vision, comfort and handling issues1), Precision1 he
- AAO: Planned Medicare Cuts Deal Heavy Blow to Nation’s Ophthalmologistshttps://modernod.com/news/aao-planned-medicare-cuts-deal-heavy-blow-to-nations-ophthalmologists/2478132/The American Academy of Ophthalmology (AAO) released a statement opposing the Centers for Medicare & Medicaid Services (CMS) proposed annual Physician Fee Schedule and Quality Payment Program